The sorafenib anti-relapse effect after alloHSCT is associated with heightened alloreactivity and accumulation of CD8+PD-1+ (CD279+) lymphocytes in marrow
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The sorafenib anti-relapse effect after alloHSCT is associated with heightened alloreactivity and accumulation of CD8+PD-1+ (CD279+) lymphocytes in marrow
Authors
Keywords
Cytotoxic T cells, Lymphocytes, T cells, Gene expression, CD coreceptors, Bone marrow cells, Leukemias, Polymerase chain reaction
Journal
PLoS One
Volume 13, Issue 1, Pages e0190525
Publisher
Public Library of Science (PLoS)
Online
2018-01-06
DOI
10.1371/journal.pone.0190525
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inhibition of FLT3 in AML: a focus on sorafenib
- (2016) A Antar et al. BONE MARROW TRANSPLANTATION
- Sorafenib-resistant hepatocellular carcinoma stratified by phosphorylated ERK activates PD-1 immune checkpoint
- (2016) Jiang Chen et al. Oncotarget
- Improvement in clinical outcome ofFLT3ITD mutated acute myeloid leukemia patients over the last one and a half decade
- (2015) Talha Badar et al. AMERICAN JOURNAL OF HEMATOLOGY
- T-cell exhaustion in the tumor microenvironment
- (2015) Y Jiang et al. Cell Death & Disease
- Current Approaches in the Treatment of Relapsed and Refractory Acute Myeloid Leukemia
- (2015) Nestor Ramos et al. Journal of Clinical Medicine
- Phase I Trial of Maintenance Sorafenib after Allogeneic Hematopoietic Stem Cell Transplantation for Fms-like Tyrosine Kinase 3 Internal Tandem Duplication Acute Myeloid Leukemia
- (2014) Yi-Bin Chen et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Myeloid-Derived Suppressor Cells as Therapeutic Target in Hematological Malignancies
- (2014) Kim De Veirman et al. Frontiers in Oncology
- Acute myeloid leukemia: 2013 update on risk-stratification and management
- (2013) Elihu H. Estey AMERICAN JOURNAL OF HEMATOLOGY
- The mTOR pathway and integrating immune regulation
- (2013) Stephen P. Cobbold IMMUNOLOGY
- mTORC1 couples immune signals and metabolic programming to establish Treg-cell function
- (2013) Hu Zeng et al. NATURE
- Impact of FLT3 Internal Tandem Duplication on the Outcome of Related and Unrelated Hematopoietic Transplantation for Adult Acute Myeloid Leukemia in First Remission: A Retrospective Analysis
- (2012) Salut Brunet et al. JOURNAL OF CLINICAL ONCOLOGY
- Ragulator-Rag Complex Targets mTORC1 to the Lysosomal Surface and Is Necessary for Its Activation by Amino Acids
- (2010) Yasemin Sancak et al. CELL
- The multikinase inhibitor Sorafenib reverses the suppression of IL-12 and enhancement of IL-10 by PGE2 in murine macrophages
- (2010) Justin P. Edwards et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Sorafenib – a small molecule with big promise?
- (2010) Tamar Tadmor et al. LEUKEMIA & LYMPHOMA
- Foxo proteins cooperatively control the differentiation of Foxp3+ regulatory T cells
- (2010) Weiming Ouyang et al. NATURE IMMUNOLOGY
- Reactivations of Cytomegalovirus, Human Herpes Virus 6, and Epstein-Barr Virus Differ with Respect to Risk Factors and Clinical Outcome after Hematopoietic Stem Cell Transplantation
- (2010) E. Jaskula et al. TRANSPLANTATION PROCEEDINGS
- Management of relapse after allo-SCT for AML and the role of second transplantation
- (2009) B N Savani et al. BONE MARROW TRANSPLANTATION
- The PI3K/Akt/mTOR pathway in innate immune cells: emerging therapeutic applications
- (2008) T Weichhart et al. ANNALS OF THE RHEUMATIC DISEASES
- Potential role of sorafenib in the treatment of acute myeloid leukemia
- (2008) Shahram Mori et al. LEUKEMIA & LYMPHOMA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now